Showing results (81-90 of 111) with videos related to
Sort By:
Pageof 12
Plos One|May 30, 2013
Improved local and systemic anti-tumor efficacy for irreversible electroporation in immunocompetent versus immunodeficient miceRobert E Neal, John H Rossmeisl, John L Robertson, et al.APL Bioengineering|June 5, 2024
Burst sine wave electroporation (B-SWE) for expansive blood-brain barrier disruption and controlled non-thermal tissue ablation for neurological diseaseSabrina N Campelo, Zaid S Salameh, Julio P Arroyo, et al.Frontiers in Veterinary Science|August 25, 2025
Case Report: Primary intracranial lymphoma and meningioma manifesting as a composite tumor in a catChristina R Vezza, Teresa L Southard, Tanya LeRoith, et al.Lasers in Surgery and Medicine|October 19, 2011
Fiberoptic microneedles: novel optical diffusers for interstitial delivery of therapeutic lightMehmet A Kosoglu, Robert L Hood, John H Rossmeisl, et al.The Journal of Membrane Biology|July 30, 2010
Intracranial nonthermal irreversible electroporation: in vivo analysisPaulo A Garcia, John H Rossmeisl, Robert E Neal, et al.Frontiers in Veterinary Science|July 24, 2019
Canine Snake-Eye Myelopathy: Clinical, Magnetic Resonance Imaging, and Pathologic Findings in Four CasesJohn H Rossmeisl, Thomas E Cecere, Gregg D Kortz, et al.Journal of Neurosurgery|July 4, 2015
Safety and feasibility of the NanoKnife system for irreversible electroporation ablative treatment of canine spontaneous intracranial gliomasJohn H Rossmeisl, Paulo A Garcia, Theresa E Pancotto, et al.Journal of Veterinary Internal Medicine|April 17, 2019
Diagnostic accuracy of stereotactic brain biopsy for intracranial neoplasia in dogs: Comparison of biopsy, surgical resection, and necropsy specimensYukitaka Kani, Thomas E Cecere, Kevin Lahmers, et al.Journal of Veterinary Internal Medicine|February 16, 2022
Incidence, risk factors, and outcomes for early postoperative seizures in dogs with rostrotentorial brain tumors after intracranial surgeryRell L Parker, John Du, Richard L Shinn, et al.Neuro-Oncology|August 20, 2020
Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomasJohn H Rossmeisl, Denise Herpai, Mindy Quigley, et al.Pageof 12